Sorbitol as a test substance for measurement of liver plasma flow in humans

被引:23
作者
Keiding, S [1 ]
Engsted, E
Ott, P
机构
[1] Aarhus Univ Hosp, PET Ctr, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Med 5, DK-8000 Aarhus, Denmark
[3] Rigshosp, Dept Med A2101, DK-2100 Copenhagen, Denmark
关键词
D O I
10.1002/hep.510280109
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The objective of this study was to evaluate whole-body removal kinetics of sorbitol, the use of extrarenal sorbitol clearance to estimate hepatic plasma flow in humans, and to compare measurements of liver flow by Fick's principle using either indocyanine green (ICG) or sorbitol. A sorbitol bolus (5 mmol/kg) was given intravenously to 6 controls for determination of sorbitol elimination capacity (SEC) and distribution volume, V-d(sorb). Sorbitol infusion (287 mu mol/min) was given to 17 liver patients and 11 controls. Extrarenal sorbitol clearance (V-x(sorb)) was calculated as infusion race (corrected for renal excretion and accumula tion in V-d(sorb)) divided by arterial concentration. Liver flow (Q(ICG))) was calculated from the ICG infusion and arterial and hepatic venous ICG concentrations by Fick's principle. Average SEC was 73 mu mol/min/kg, V-d(sorb) was 0.16 L plasma per kilogram, and in vivo V-d(sorb) was 3 mmol/L. Renal sorbitol excretion rate was 0.03 to 0.31 of infusion rate. Extrahepatic extrarenal removal was not significantly different from zero but varied considerably. Hepatic extraction fraction of sorbitol, (E-sorb), measured by liver vein catheterization, was 0.35 to 1.04 (median, 0.86) in cirrhotic patients and 0.90 to 0.98 (0.86) in controls. The requirements for using Cl-x(sorb) as an estimate of Q(ICG) was not violated by the data in controls, Cl-x(sorb)/Q(ICG) 0.70 to 1.55 [median, 1.08]), whereas there was a systematic underestimation in cirrhotic patients (0.72-1.08 [0,85]). Liver flow calculated by Fick's principle using either sorbitol or ICG agreed well. E-sorb > E-ICG in each individual except one. Curvilinear relationship between E-sorb and E-ICG was in agreement with different kinetic parameters for sorbitol and ICG, and did not require additional assumption of intrahepatic shunts.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 24 条
[1]   Assessment of functional liver mass and plasma flow in acromegaly before and after long-term treatment with octreotide [J].
Avagnina, P ;
Martini, M ;
Terzolo, M ;
Sansoe, G ;
Peretti, P ;
Tinivella, P ;
Pia, A ;
Molino, G ;
Angeli, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (01) :109-113
[2]   EFFECTS OF NIFEDIPINE ON FUNCTIONAL LIVER PLASMA-FLOW IN NORMAL SUBJECTS AND IN PATIENTS WITH CIRRHOSIS [J].
AVAGNINA, P ;
SANSOE, G ;
MARTINI, M ;
PERETTI, P ;
TINIVELLA, M ;
MOLINO, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) :368-373
[3]  
BASS L, 1976, Journal of Theoretical Biology, V61, P393, DOI 10.1016/0022-5193(76)90026-6
[4]  
Bergmeyer HU, 1975, METHOD ENZYMAT AN, P1323
[5]  
CLEMMESEN O, IN PRESS HEPATOLOGY
[6]   GALACTOSE CLEARANCE MEASUREMENTS AND LIVER BLOOD-FLOW [J].
KEIDING, S .
GASTROENTEROLOGY, 1988, 94 (02) :477-481
[7]   DRUG ADMINISTRATION TO LIVER PATIENTS - ASPECTS OF LIVER PATHOPHYSIOLOGY [J].
KEIDING, S .
SEMINARS IN LIVER DISEASE, 1995, 15 (03) :268-282
[8]   CAN INTRAHEPATIC SHUNTING BE MEASURED [J].
KEIDING, S .
DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (09) :1185-1188
[9]   MICHAELIS-MENTEN KINETICS OF GALACTOSE ELIMINATION BY ISOLATED PERFUSED PIG LIVER [J].
KEIDING, S ;
JOHANSEN, S ;
WINKLER, K ;
TONNESEN, K ;
TYGSTRUP, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1976, 230 (05) :1302-1313
[10]  
Keiding S, 1991, OXFORD TXB CLIN HEPA, V1st, P78